Source: BioPortfolio

Hyperion Therapeutics: Hyperion Therapeutics Inc. HPTX Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250

SummaryHyperion Therapeutics Inc. Hyperion is a biopharmaceutical company. It develops and commercializes novel drugs for the treatment of orphan diseases and hepatology disorders. Ravicti the company's first approved product is indicated for use as a nitr...

Read full article »
Hyperion Therapeutics's Competitors | Hyperion Therapeutics's News | Hyperion Therapeutics's Financials
Stay up-to-date with the latest news on Hyperion Therapeutics
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100

Read more
Stay up-to-date with the latest news on Hyperion Therapeutics